Bharat Biotech IPO soon? Vaccine maker plans to raise $500 million from stock market, says report
Bharat Biotech IPO soon? Vaccine maker plans to raise $500 million from stock market, says report is drawing significant interest across the industry.
Bharat Biotech is seeking to raise over $500 million through an IPO. Discussions are ongoing, and details may change. Established in 1996, the company has distributed over 9 billion vaccines worldwide, including those for Covid-19 and hepatitis B.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Stock Market Awaits Iran War News, Oil Prices' Next Move. Here's What To Do.
- Tharoor upset by AI-generated fake video, not just for misinformation, but also for bad English
- Shield AI Signs Contract with Taiwan's National Chung-Shan Institute of Science and Technology to Accelerate and Indigenize Taiwan-Developed AI Pilots
- ET Leads Official Coverage of AI Movement
Source: Original →